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STRUCTURED ABSTRACT  
Purpose. The trabeculae of the left ventricle vary in health and disease but their measurement 
is difficult. Fractal analysis of cardiac magnetic resonance (MR) images can measure 
trabecular complexity as a fractal dimension (FD). We report the development of easy-to-use 
MR fractal tools deployed on platforms accessible to all. 
 
Materials and Methods. This HIPAA-compliant study was approved by the local 
institutional review board. Participants provided written informed consent. The original 
MATLAB implementation (region-based level set segmentation and box-counting algorithm) 
was recoded for two platforms (OsiriX and a clinical MR reporting platform [cvi42, Circle 
Cardiovascular Imaging Inc.]). For validation 100 subjects were scanned at 1.5 Tesla and 20 
imaged twice for inter-study reproducibility. Cines were analysed by the 3 tools and FD 
variability determined. Manual trabecular delineation by an expert reader (R1) provided 
ground truth contours for validation of segmentation accuracy by point-to-curve (P2C) 
distance estimates. Manual delineation was repeated by R1 and a second reader (R2) on 15 
cases for intra/inter-observer variability.  
 
Results. FD by OsiriX and the clinical MR reporting platform showed high correlation with 
MATLAB values (correlation coefficients: 0.96 [95% CI: 0.95-0.97] and 0.96 [0.95-0.96]) 
and high inter-study and intra-platform reproducibility. Semi-automated contours in OsiriX 
and the clinical MR reporting platform were highly correlated with ground truth contours 
evidenced by low P2C errors: 0.882 ± 0.76 mm and 0.709 ± 0.617 mm. Validity of ground 
truth contours was inferred from low P2C errors between readers (R1-R1: 0.798 ± 0.718 mm; 
R1-R2: 0.804 ± 0.649 mm). 
 
  
Conclusion. This set of accessible fractal tools that measure trabeculation in the heart have 
been validated and released to the cardiac MR community (http://j.mp/29xOw3B) to 
encourage novel clinical applications of fractals in the cardiac imaging domain.  
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Abnormal and excessive trabeculation is observed across a broad spectrum of heart muscle 
diseases (e.g. left ventricular noncompaction [LVNC](1, 2), hypertrophic cardiomyopathy 
[HCM](3), sickle cell anaemia(4), congenital heart disease(5)). Consequently, robust 
quantification of trabeculae is gaining interest for overt disease definition, e.g. LVNC(6), for 
tracking changes over time(7), and for detecting early disease(8).  
Cine steady-state free precession (SSFP) cardiac magnetic resonance (MR) imaging is 
considered the modality of choice for the visualisation of trabeculae as it has unrestricted 
imaging planes, high spatial definition and blood:myocardial contrast, especially apically 
where echocardiography struggles.  
Trabecular quantification is not standardized. A variety of MR-based methods have been 
proposed(9)) including some semi-automated  approaches. However, a clinically useable 
technique validated against ground truths is not widely available and manual delineation by 
an experienced reader remains the standard approach despite being time consuming and 
observer dependent. To transition some of these semi-automated methods from research tools 
into more widely-used applications for cardiac MR, equivalent accessible software products 
are needed for sharing across the cardiac MR community.   
We recently described a fast in-house fractal method (coded in MATLAB, The MathWorks, 
Inc., Natick, Massachusetts) that measures the complexity of endocardial borders as a 
continuous variable−the fractal dimension [FD]. Fractal analysis applied to cardiac MR by 
individual research groups has demonstrable utility for describing trabecular phenotypes in 
LVNC(2) (where the optimal diagnostic threshold for maximal apical FD was ≥1.3), heart 
failure with reduced and preserved ejection fraction(10), and overt and subclinical HCM(3). 
  
Using this method, the endocardial complexity of the normal human LV has been shown to 
change in a characteristic pattern from base to apex, recapitulating changes along the length 
of the LV in the developing mouse heart(11), where the transformation from spongy to 
compact myocardium, coincides with the development of the coronary arteries. The fractal 
signature of the adult human heart has been shown to differ by ethnicity, LV mass, coexistent 
hypertension, and increased body mass index(6). Cardiac MR fractal analysis is currently 
being used to understand the FD of the adult human heart at scale, in both the UK Biobank 
Study (n=100,000) and the US Multi-Ethnic Study of Atherosclerosis (MESA, >3,000). To 
progress this imaging biomarker (the FD), explore its practical clinical utility in patients, 
ensure research transparency, mitigate against potential biases in publication, and encourage 
novel applications by third parties, a set of easy-to-use community-accessible fractal tools 
deployed on platforms familiar to cardiac imagers are needed. Such tools will allow the FD to 
exit expert centers allowing real world data handling of the biomarker to commence. 
This technical report summarises the development, validation and release of fractal analysis 
tools (Figure 1) built for both an open platform, OsiriX (v5.0.1, 64-bit, Revision 10290, 
http://www.osirix-viewer.com, Video 1) and a clinical MR reporting platform (cvi42, Circle 
Cardiovascular Imaging Inc., Calgary, Canada, Video 2). 
 
MATERIALS AND METHODS 
Study Participants 
Human cardiac MR studies were conducted with the approval of our local Institutional 
Review Board (IRB) and an ethics committee of the UK National Research Ethics Service 
approved the generic analysis of anonymized clinical scans. At the time of enrolment all 
participants gave written informed consent conforming to the declaration of Helsinki (V. 
revision, 2000). The authors had control of the data and information submitted for 
  
publication. This study conforms to the Standards for Reporting of Diagnostic Accuracy 
(STARD)(12). 
One-hundred individuals (aged 18 - 75 years, 100% Caucasian) who underwent cardiac MR 
imaging at The Heart Hospital part of University College London Hospitals Foundation 
Trust, between January 2010 and February 2012. 18 Of the 23 healthy volunteers, all the 
LVNC cases, and 30 of the 57 HCM participants have been previously reported(2, 3).  These 
prior articles dealt with FD comparisons between health and disease whereas in this 
manuscript we report on the development of community accessible fractal tools, test 
segmentation accuracy and report on system reproducibility. Healthy volunteers had no 
history of cardiovascular disease or hypertension, a normal physical examination, no family 
history of inheritable cardiomyopathy or sudden cardiac death and no personal history of 
unexplained syncope. LVNC and HCM cases had been recruited from a dedicated 
cardiomyopathy clinic (recruitment criteria for LVNC and HCM cases and exclusion criteria 
for all participants were previously described(2, 3)). Twenty individuals (15 healthy 




Standard clinical scans were performed using a 1.5 Tesla magnet (Avanto, Siemens Medical 
Solutions, Erlangen, Germany). Cardiac MR short-axis volumetric studies(13) were acquired 
in accordance with Society for Cardiovascular Magnetic Resonance (SCMR) guidelines, 
from retrospectively-gated, breath-held, balanced, cine SSFP (slice thickness, 7 mm; inter-
slice gap, 3 mm; flip angle, 60 - 80°; repetition time, 3 ms; echo time, 1.33 ms; field of view 
read typically, 380 mm; phase resolution, 75%; typical acquired voxel size 1.5 x 1.7 mm; 




Fractal analysis was performed as previously described(14) on the end-diastolic frames of 
each short-axis cine slice in the LV stack. Cardiac MR slices underwent automatic scaling 
according to Digital Imaging and Communications in Medicine (DICOM) pixel spacing 
metadata as the first image-processing step. After loading the cine stack, the graphical user 
interfaces (GUI) prompted the user to define the region-of-interest (ROI) using an ROI-poly 
tool applied to the subendocardium. Step 1 required user interaction but subsequent steps 
were automated and consisted of image segmentation to extract the endocardial contour 
followed by determination of the FD. In Step 2 a region-based level set segmentation 
algorithm(14) was used to extract endocardial contours before conducting box-counting 
fractal analysis (Step 3) as previously described(2) (Figure 2). The level set algorithm(14) is 
able to achieve subpixel accuracy in the extraction of the endocardial contours and deal with 
the intensity inhomogeneity in the images. The subpixel accuracy of the endocardial contour 
is necessary for the precise computation of the FD of the contours. On account of partial 
volume effects that tended to affect the most apical of the LV cine slices, apical endocardial 
contours with a bounding box global height or global width less than 49 pixels were 
automatically excluded from fractal analysis by the software. Results to three decimal places 
are automatically labelled and parsed into a text file for statistical analysis.  
 
Assessment Of Segmentation Accuracy  
Execution time for the automatic level set segmentation method in the 3 implementations 
(MATLAB, OsiriX, the clinical MR reporting platform) was timed and segmentation results 
compared with a ground truth of manual delineation, by an experienced reader (R1, >3 years 
experience in cardiac MR), blinded to other data. Manual contouring was performed in 
  
accordance with SCMR guidelines on standardized image interpretation and post-processing 
of cardiac MR(15) images except that trabeculae and papillary muscles were outlined and not 
included in the blood pool. Error accuracy was estimated as the mean perpendicular distance 
between the two sets of contour coordinates denoted as point-to-curve mean (P2C) error. P2C 
errors in the basal half of the LV were also compared to the apical half (where contouring is 
known to be harder). Intra-observer analysis was separated by at least 7 days, and inter-
observer analysis was also performed (R2, 1 year experience in cardiac MR). 
 
Assessment Of Within Platform Reproducibility 
As the user interacts with the software platforms by applying the ROI-poly tool to the 
subendocardium, we calculated the intraobserver (R3 vs R3) and interobserver (R3 vs R2) 
variability of FD across 30 randomly-selected scans (R3, >3 years experience in cardiac MR). 
Results for the original MATLAB tool were previously reported.(3) 
 
Statistical Analysis 
Statistical analysis was performed in R (version 3.0.1, The R Foundation for Statistical 
Computing). Data was curated using Research Electronic Data Capture (REDCap) 
infrastructure (instance: REDCapSECURE(16)). Descriptive data are expressed as mean ± 
standard deviation unless otherwise stated. Distribution of data was assessed on histograms 
using Shapiro-Wilk test. Two-way random, single measures intraclass correlation coefficient 
(ICC) was used to assess reproducibility (absolute agreement) of FD calculates across 
platforms and between readers within platforms. The Bland-Altman method was used to 
estimate the mean difference (bias) and 95% limits of agreement (±1.96 standard deviation) 
between paired FD measurements for each of OsiriX and the clinical MR reporting platform 
  
versus MATLAB. Differences in P2C errors between basal and apical sets were compared by 
unpaired t test. A two-sided P value < 0.05 was considered significant. 
 
RESULTS 
Participant Characteristics And Fractal Dimensions 
Table 1 summarizes patient baseline characteristics and FD results by the 3 methods. A 
whole short-axis stack fractal analysis was achievable in all 100 participants using all 3 
implementations. No participant took more than 4 minutes to analyse (a typical slice takes 
<10 s to analyse). A user manual for the OsiriX tool is provided in Supplementary Material 
1. There was a high ICC for slice-specific FD by the OsiriX or clinical MR reporting 
platform versus MATLAB respectively: 0.96 [95% confidence interval (CI), 0.95-0.97] and 
0.96 [95% CI, 0.95-0.96] respectively. Fractal dimension values obtained from MATLAB 
and the two implementations demonstrated narrow limits of agreement with minimal bias 
(Figure 3). There was a high ICC for inter-study slice-specific FD by MATLAB, OsiriX and 
the clinical MR reporting platform (respectively: 0.97 [95% CI, 0.95-0.98], 0.96 [95% CI, 
0.94-0.97], 0.96 [95% CI, 0.94-0.97]). 
 
Ground Truth Contours And Segmentation Accuracy 
Repeated manual delineations of trabeculae by expert readers showed low mean P2C errors: 
R1-R1: 0.798 ± 0.718 mm; R1-R2: 0.804 ± 0.649 mm. Expert manual delineation and the 
semi-automatic trabecular contours agreed well with low mean P2C errors, Table 2. The 
differences between manual and semi-automated contours were in the same range as intra- 
and inter-observer manual variability (0.882 ± 0.76 mm and 0.709 ± 0.617 mm for OsiriX 
and the clinical MR reporting platform respectively across all slices studied). Accuracy of 
endocardial segmentation was higher in the basal than in the apical half of the LV (P 
  
consistently < 0.05 for differences, see Table 2). This trend was observed for all experiments 
(manual delineations as well as semi-automated segmentations) but accuracy of apical 
segmentation was still sufficiently accurate, with all P2C errors remaining below 1mm.  
 
Within Platform Reproducibility 
Intra- and inter-observer reproducibility of FD per slice was high for both platforms: OsiriX - 
ICCs: 0.987, 95% CI 0.973-0.996 and 0.986, 95% CI 0.973-0.996 respectively; clinical MR 




There is information contained in the trabecular architecture of the heart.  Fractal analysis has 
the advantages that it measures complexity (a key biological phenomenon), is a continuous 
variable (like LV wall thickness or ejection fraction), and alters in health and disease.  It can 
also be used with different imaging techniques and at different scales of observation−from 
adult human cardiac MR to high-resolution episcopic microscopy for development (11, 17). 
Here, the software for its analysis is shown to be easy-to-use after brief training, fast, 
reproducible and available, including both a free plugin for OsiriX and a plugin embedded in 
a widely-used clinical MR reporting platform. We commend the technique specifically to 
clinical researchers aiming to quantify LV trabecular complexity but emphasize that to do 
this, the level-set segmentation method has been designed to segment trabeculae out of the 
blood pool−this contrasts with other semi-automated segmentation tools recommended for 
standardized quantification of LV cavity size, function and mass where trabeculae and 
papillary muscles are sometimes included in the blood pool to improve reproducibility(18) 
although there is still no universal agreement regarding this issue.  
  
Published cardiac MR data on LV volume analyses (that exclude trabeculae) have already 
highlighted the better performance of basal/midventricular segmentation compared to the 
apex(19) (where partial volume effects are likely responsible). Relevant to the case of LV 
trabecular segmentation, we therefore included experiments comparing segmentation 
accuracy of slices in the basal LV compared to the apex. We report that whether by expert 
manual delineation or semi-automation, basal slices performed better than apical, but P2C 
errors for apical segmentation using the region-based level set method with bias field 
correction was still low at < 1mm.  
Technically, we describe the 3 fractal implementations (in MATLAB, OsiriX and a clinical 
MR reporting platform), validated their results against ground truth contours and then applied 
each code to a set of clinical MR datasets demonstrating how, if caution is paid in the 
acquisition of the cine images, in their handling, and in the implementation of the code, these 
implementations can summarise LV trabecular complexity to match the standards of 
delineation by an expert clinical reader. These tools can now be applied to real world cardiac 
MR data to permit further validation and multi-center verification and it is possible that the 
FD of the LV may prove relevant as a clinical adjunct for the refined diagnoses of 
cardiomyopathy. The fractal method has already been used to describe FD ranges for healthy 
subjects(6): white (1.206 ± 0.08), Chinese-Americans (1.197 ± 0.07), Hispanics (1.211 ± 
0.07), African–American (1.223 ± 0.08); left ventricular noncompaction (1.392 ± 0.01); heart 
failure with preserved and reduced ejection fraction(10) (mean FD: 1.26, 1.27 respectively); 
and overt hypertrophic cardiomyopathy(3) (1.37 ± 0.08). 
The impact on FD of varying slice thickness(3) (6 vs. 7 vs. 8 mm), magnetic field strength(8) 
(1.5 vs. 3-Tesla), image sequence (fast gradient echo vs. cine SSFP) and patient-repositioning 
(inter-study reproducibility), has been previously reported. Future research should test the 
impact on FD of contrast administration, choice of phase (other than end-diastolic used so 
  
far) and temporal resolution, and its feasibility for right ventricular trabecular quantification. 
Performance of the level set segmentation has not been tested on real time cines or in the 
presence of arrhythmia and motion artefacts. The tools are quite generic and fractal plugins 
could now similarly be developed for other clinical MR reporting platforms (e.g. Medis, 
CMRtools). Through optimization of the level set function we believe it is plausible to expect 
future applications to other scenarios, including other imaging modalities (e.g. computerized 
tomography) and other cardiac structures (e.g. the right ventricle, atria/atrial appendage). The 
pursuit of such endeavors is encouraged and facilitated by products of this kind. 
A fundamental question arises−how should a fractal analysis of the myocardial trabeculae be 
incorporated into clinical care?  There are key areas to focus on. Trabecular development and 
the myocardial changes that take place during cardiac embryogenesis are incompletely 
understood processes and herein lies one potential application of fractal analysis. Abnormal 
trabeculae are often a disease feature (epiphenomenon) rather than a pathological entity per-
se(20). For example, HCM exhibits abnormal trabecular architecture and there may be a 
predictive role for its description in early disease(8).  It may be that a high or low FD in a 
newly-presenting dilated cardiomyopathy patient may point to a specific genetic abnormality 
or prognosis, but these hypotheses are as yet unexplored. Our disease classifications are 
defined by our current state of knowledge, itself defined mainly by our tools and technologies 
and how we use them. Here cardiac MR can be a game-changer−tied to new accessible 
analytics it has the potential to fine-tune established disease definitions.  
Limitations of this study include the reliance upon the use of Mac computers running OS X to 
support OsiriX, although the clinical MR reporting platform is not limited to Mac computers 
(albeit a commercial product). The clinical utility of cardiac MR fractal analysis in 
discriminating health from disease (left ventricular noncompaction, heart failure, HCM) was 
previously demonstrated and beyond the scope of this work where the focus was to report the 
  
development, validity and reproducibility, of easy-to-use and accessible MR fractal tools. For 
this we used 100 cardiac MR datasets (23% healthy, 77% participants with disease). Our 
analysis refers only to 2D images acquired along the long axis of the LV and future research 
should explore its extension to the more realistic case of 3D trabecular networks imaged by 
3D whole-heart cardiac MR. Only the level set segmentation method was used−other 
classical image segmentation methods, such as visual thresholding, edge-detection and 
region-grow were not investigated on account of the several desirable advantages of the level 
set method discussed elsewhere(14). 
In conclusion, fractal analysis of cardiac MR data measures LV endocardial complexity and 
provides a fractal dimension. We show that this semi-automated system, developed into 
accessible community tools, is able to achieve a mean point-to-curve error of less than 1 mm 
for all digital images studied. This set of accessible fractal tools that measure trabeculation in 
the adult human left ventricle are described and the products are now both publically 
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Table 1 Characteristics of test populations and FD results. 
Population  
(n = 100) 
 Healthy volunteers  
(n = 23)  
LVNC  
(n = 20) 
HCM*  
(n = 57) 
Age (years)   38 ± 12 48 ± 16 50 ± 19 
Gender (M/F)  10/13 14/6  32/25  
Height (cm)  169 ± 7 166 ± 8 170 ± 9 
Weight (kg)  80 ± 16 73 ± 14 75 ± 15 
Ejection fraction|| (%)  71 ± 6 53 ± 16 78 ± 9 
LVEDVi|| (mL)  69 ± 17 102 ± 43 65 ± 18 
Total number of cine slices  138 108 355 
FDMaxApical §[ ]     
MATLAB  1.18 ± 0.09 1.35 ± 0.11 1.33 ± 0.09 
OsiriX  1.17 ± 0.07 1.33 ± 0.12 1.33 ± 0.10 
Clinical MR reporting platform  1.19 ± 0.08 1.34 ± 0.13 1.33 ± 0.09 
Data are presented as and mean ± standard deviation except where otherwise stated. 
* HCM population included patients with overt as well as subclinical HCM. 
§ FDMaxApical [unitless value] was calculated as the maximal FD value in the apical half of the LV. 
|| Ejection fraction and LV volumes were determined in all study participants using CMRtools (CVIS, 
London, UK). 
F = female; HCM = hypertrophic cardiomyopathy; LVEDVi = left ventricular end-diastolic volume 







Table 2 P2C data summarizing reproducibility of ground truths and segmentation accuracy of 
the two fractal tools. 
Slices 
P2C Errors (mm) 
Ground Truth Contours 
OsiriX vs.  
R1 Ground Truth 
(n = 30 stacks, 
203 slices) 
Clinical MR reporting 
platform vs.  
R1 Ground Truth 
(n = 30 stacks, 
203 slices) 
R1-R1  
(n = 15 stacks, 
98 slices) 
R1-R2 
(n = 15 stacks,  
98 slices) 
All  0.798 ± 0.718 0.804 ± 0.649 0.882 ± 0.760 0.709 ± 0.617 
Basal 0.711 ± 0.676 0.644 ± 0.543 0.819 ± 0.698 0.595 ± 0.549 
Apical 0.935 ± 0.803 0.986 ± 0.772 0.984 ± 0.849 0.835 ± 0.695 
Data are presented as mean ± standard deviation. For a perfect overlap between the regions P2C error 



















Figure 1. Community accessible fractal tools developed for cardiac magnetic resonance.  
Appearance of the graphical user interfaces in the original MATLAB implementation (left) 
and the equivalent community-accessible tools deployed in OsiriX (middle), and the clinical 
MR reporting platform (right, cvi42). The FD is calculated for each slice in the LV short axis 
stack. The number of slices needed for coverage would vary depending on heart size. The 
most apical ventricular section was excluded from all analyses because of partial voluming 
effects. Maximal apical FD was derived from the apical half of the LV stack by consistently 














Figure 2. Region-based level set segmentation and box-counting FD applied to cardiac 
MR. 
The only user-dependent involves placement of a ROI (in green) at the subendocardium of 
the original cine MR image (A, left panel) to trigger masking. All ensuing steps are 
automated. Pixels outside the ROI are set to zero. In the level set method contours are 
  
represented as the zero level set of the level set function and the segmentation problem is 
solved in a principled way using calculus of variations and partial differential equations. The 
method simultaneously estimates and corrects for any bias field across the MR image (A, 
right panel: seen here as an intensity inhomogeneity across the blood pool). Histograms (B) 
of the original images (left) and bias corrected image (right). There are 2 well-defined and 
well-separated peaks in the histograms of the bias corrected image (red asterisks), each 
corresponding to a tissue or the background in the image. The original image does not have 
such well-separated peaks due to the mixture of the intensity distribution caused by the bias. 
In the standard box-counting fractal analysis method a series of grids of boxes of ever 
decreasing size (C) are applied to the digital image (only 3 grid sizes shown in this 
illustration). For every grid size the software counts the smallest number (N) of boxes, each 
of side length e, that contain pixel detail (overlies contour pixels) and the number of pixels 
per box. In this pictorial representation, only 1 starting grid position and 3 box sizes are 
shown but the complete analysis for this slice actually involves >50 box sizes for each of the 
4 starting grid positions. The empirical box-counting FD (1.308 in this example) is estimated 
from the slope of a regression line when log(Ne) is plotted against log(1/e), therefore FD = 
log (Ne)/log(1/e) (D). The analysis is automatically replicated on the same image 4 times, 
using an identical series of grid calibres but 4 different mathematically derived starting 
coordinates. The final FD for the contour set is computed as the mean of the 4 FDs. FD = 








Figure 3. Bland Altman plots comparing FD results across platforms. 
Differences between maximal apical FD per participant calculated by automatic segmentation 
in MATLAB compared to OsiriX (A) and the clinical MR reporting platform (B). 
Discontinuous middle line indicates mean and discontinuous horizontal lines above and 
below indicate mean difference ± 1.96SD. The bias of each method is represented by the gap 
between the ‘Mean’ line and the x axis corresponding to a zero differences. For the OsiriX 
method there is a positive but minimal bias of < 0.01. FD = fractal dimension; Max = 
maximal; SD = standard deviation; [ ] = unitless value. 
 
VIDEOS 
Video 1. Fractal analysis using the OsiriX tool for cardiac MR.  
 
Video 2. Fractal analysis using the tool for the clinical MR reporting platform.  
 
